The PRICER team connects healthcare economics & medical expertise to modern investment management.
A brief introduction to our founders:
Matthijs versteegh
Former consultant to public (World Health Organization, World Bank, HTA bodies, European Commission) and private (start-ups and listed industry) institutions, Matthijs is a PhD health economist. He served as director at the institute for Medical Technology Assessment (iMTA), a leading health economics research institute until founding Huygens & Versteegh in 2022.
Michel uitermarkt
Formerly with Morgan Stanley Investment Management as a financial analyst, Michel spent over five years in a managerial role at international strategy consulting firm OC&C. He holds an MSc in finance & investments from RSM Erasmus University.